Corvus Pharmaceuticals (CRVS) Cash & Equivalents Growth (1y) (2016 - 2026)
Corvus Pharmaceuticals (CRVS) Cash & Equivalents Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 23.81% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 71.81% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Corvus Pharmaceuticals | 1.17 Bn | 934.14 Mn | - | 702.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 702.20% |
| Dec 31, 2025 | -47.64% |
| Sep 30, 2025 | -38.74% |
| Jun 30, 2025 | -1.01% |
| Mar 31, 2025 | -32.95% |
| Dec 31, 2024 | -30.74% |
| Sep 30, 2024 | -76.72% |
| Jun 30, 2024 | 93.80% |
| Mar 31, 2024 | -22.77% |
| Dec 31, 2023 | -4.10% |
| Sep 30, 2023 | -18.23% |
| Jun 30, 2023 | -73.11% |
| Mar 31, 2023 | -69.31% |
| Dec 31, 2022 | -79.26% |
| Sep 30, 2022 | -65.99% |
| Jun 30, 2022 | -51.66% |
| Mar 31, 2022 | -30.25% |
| Dec 31, 2021 | 285.65% |
| Sep 30, 2021 | 214.65% |
| Jun 30, 2021 | 184.54% |